Education
About Us
Working with TipRanks
Follow Us
CytoDyn (CYDY)
:CYDY
Total Valuation
CytoDyn has a market cap or net worth of $419.79M. The enterprise value is $112.00M.
Market Cap$419.79M
Enterprise Value$112.00M
Share Statistics
CytoDyn has 1,232,432,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,232,432,900
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
CytoDyn’s return on equity (ROE) is 0.43 and return on invested capital (ROIC) is 41.89%.
Return on Equity (ROE)0.43
Return on Assets (ROA)-4.48
Return on Invested Capital (ROIC)41.89%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee0.00
Profits Per Employee-5.54M
Employee Count9
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of CytoDyn is -3.10. CytoDyn’s PEG ratio is 0.04.
PE Ratio-3.10
PS Ratio0.00
PB Ratio-2.00
Price to Fair Value-1.32
Price to FCF-8.72
Price to Operating Cash Flow-8.72
PEG Ratio0.04
Income Statement
In the last 12 months, CytoDyn had revenue of 0.00 and earned -49.84M in profits. Earnings per share was -0.05.
Revenue0.00
Gross Profit-29.00K
Operating Income-18.06M
Pretax Income-49.84M
Net Income-49.84M
EBITDA-18.03M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -4.75M and capital expenditures 0.00, giving a free cash flow of -4.75M billion.
Operating Cash Flow-4.75M
Free Cash Flow-4.75M
Free Cash Flow per Share>-0.01
Dividends & Yields
CytoDyn pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.82
52-Week Price Change128.57%
50-Day Moving Average0.32
200-Day Moving Average0.21
Relative Strength Index (RSI)42.95
Average Volume (3m)2.74M
Important Dates
CytoDyn upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
CytoDyn as a current ratio of 0.13, with Debt / Equity ratio of -32.34%
Current Ratio0.13
Quick Ratio0.13
Debt to Market Cap0.19
Net Debt to EBITDA-1.50
Interest Coverage Ratio-2.08
Taxes
In the past 12 months, CytoDyn has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CytoDyn EV to EBITDA ratio is -10.07, with an EV/FCF ratio of -16.53.
EV to Sales0.00
EV to EBITDA-10.07
EV to Free Cash Flow-16.53
EV to Operating Cash Flow-16.53
Balance Sheet
CytoDyn has $16.40M in cash and marketable securities with $27.32M in debt, giving a net cash position of $10.92M billion.
Cash & Marketable Securities$16.40M
Total Debt$27.32M
Net Cash$10.92M
Net Cash Per Share<$0.01
Tangible Book Value Per Share-$0.12
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for CytoDyn is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―